New primary prevention guidelines for women addresses both risk factors unique to women, such as auto-immune disease and pregnancy related factors, as well as differences in traditional risk factors such as hypertension, diabetes and hyperlipidemia. The new guidelines also covers topics that have been debated over the years such as hormone replacement therapy and aspirin.
Director of the Women's Cardiovascular Center, Leslie Cho, MD, summarizes the findings and highlights what providers should know when assessing women for cardiovascular risk.